NMN supplement shows promise for prediabetes in early human test
NCT ID NCT04571008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a supplement called nicotinamide mononucleotide (NMN) can improve how the body handles sugar in people with prediabetes. Researchers gave NMN to 56 adults with higher-than-normal blood sugar and measured changes in insulin sensitivity and glucose tolerance. The goal was to see if benefits seen in mice also occur in humans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Quitting smoking may also ward off diabetes — a trial puts the dual strategy to the test
- Peanut butter at breakfast may tame blood sugar and sharpen the mind
- Glucose monitors may guide teens away from diabetes
- Can short bursts of stairs beat a long walk for prediabetes?
- Could eating in an 8-Hour window beat calorie counting for prediabetes?
- Could vinegar and fasting fix prediabetes cholesterol?